Nasotasone (Mometasone Furoate)

Mometasone furoate, the active ingredient in Nasotasone, is a corticosteroid (glucocorticoid) presented as a nasal spray for nasal use. It is indicated for the treatment of allergic rhinitis in adults and children, helping to relieve nasal congestion, sneezing and itching. GNH USA supplies Nasotasone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate nasal spray acts on the inflammatory pathways of the nasal mucosa to control allergic rhinitis. - Allergic rhinitis: reduces nasal congestion, sneezing, itching and rhinorrhea. - Seasonal allergic rhinitis: provides symptom relief during pollen seasons. - Perennial allergic rhinitis: controls year‑round nasal inflammation caused by indoor allergens.

Mometasone furoate nasal spray may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation - Epistaxis (nosebleeds) - Headache - Altered taste or bitter taste - Throat irritation or dryness - Cough

Serious or Rare Side Effects: - Adrenal suppression with prolonged high‑dose use - Cataracts or glaucoma - Fungal infection of the nasal passages - Severe allergic reaction (anaphylaxis) - Nasal septum perforation - Vision changes or ocular discomfort

Before using Nasotasone, consider the following safety measures. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: discuss potential risks with a physician. - Children: use only as prescribed and monitor for growth effects. - Long‑term therapy: periodic assessment for systemic corticosteroid exposure is recommended. - Concomitant nasal surgery or trauma: postpone use until healing is complete. - Store at room temperature: keep in the original container, protect from moisture and direct heat.

Mometasone furoate nasal spray can interact with other medicines, affecting safety or efficacy.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise local drug exposure. - Live vaccines: potential reduction in vaccine efficacy.

Moderate Interactions (Monitor Closely): - Antihistamines: additive sedation is uncommon but monitor for drowsiness. - Nasal decongestants (e.g., oxymetazoline): may increase local irritation. - Antifungal nasal sprays: possible additive mucosal irritation.